0001213900-18-002828.txt : 20180313 0001213900-18-002828.hdr.sgml : 20180313 20180313094845 ACCESSION NUMBER: 0001213900-18-002828 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180312 DATE AS OF CHANGE: 20180313 EFFECTIVENESS DATE: 20180312 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Amarantus Bioscience Holdings, Inc. CENTRAL INDEX KEY: 0001424812 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-307539 FILM NUMBER: 18685431 BUSINESS ADDRESS: STREET 1: 655 MONTGOMERY STREET STREET 2: SUITE 900 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: (408) 737-2734 MAIL ADDRESS: STREET 1: 655 MONTGOMERY STREET STREET 2: SUITE 900 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 FORMER COMPANY: FORMER CONFORMED NAME: AMARANTUS BIOSCIENCE, INC. DATE OF NAME CHANGE: 20130114 FORMER COMPANY: FORMER CONFORMED NAME: Amarantus BioSciences, Inc. DATE OF NAME CHANGE: 20110527 FORMER COMPANY: FORMER CONFORMED NAME: Jumpkicks, Inc. DATE OF NAME CHANGE: 20080123 D 1 primary_doc.xml X0708 D LIVE 0001424812 Amarantus Bioscience Holdings, Inc. 953 INDIANA STREET SAN FRANCISCO CA CALIFORNIA 94104 (917) 686-5317 NEVADA None AMARANTUS BIOSCIENCE, INC. Amarantus BioSciences, Inc. Jumpkicks, Inc. Corporation true 2013 Gerald Commissiong 953 Indiana Street San Francisco CA CALIFORNIA 94104 Executive Officer Director Chief Executive Officer John Commissiong 953 Indiana Street San Francisco CA CALIFORNIA 94104 Executive Officer Director Chief Scientific Officer Donald Huffman 953 Indiana Street San Francisco CA CALIFORNIA 94104 Director Robert Harris 953 Indiana Street San Francisco CA CALIFORNIA 94104 Director Steven Spence 953 Indiana Street San Francisco CA CALIFORNIA 94104 Director Pharmaceuticals Decline to Disclose 06b false 2018-02-26 false true true true false 0 Dominick & Dickerman LLC 7344 Clark MacKenzie Jr. 2573853 570 LEXINGTON AVENUE, SUITE 4200 NEW YORK NY NEW YORK 10022 NY NEW YORK false Dominick & Dickerman LLC 7344 Steven Spence 2667444 570 LEXINGTON AVENUE, SUITE 4200 NEW YORK NY NEW YORK 10022 NY NEW YORK false Paulson Investment Company LLC 5670 Christopher Roberts 6438956 40 WALL STREET, 23RD FLOOR NEW YORK NY NEW YORK 10022 NY NEW YORK false Paulson Investment Company LLC 5670 Zvi Ben-Zvi 2994766 40 WALL STREET, 23RD FLOOR NEW YORK NY NEW YORK 10022 NY NEW YORK false 1500000 300000 1200000 false 1 37500 true 0 Dominick & Dickerman LLC will receive fees in the amount of 1.25% of the amount of securities sold and Paulson Investment Company LLC will receive fees in the amount of 11.25% of the amount of securities sold. 20000 true false Amarantus Bioscience Holdings, Inc. /s/ Gerald Commissiong Gerald Commissiong Chief Executive Officer 2018-03-12